Navigation Links
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Date:5/26/2009

Officer, Robert I. Blum. "We are looking forward to now expanding our collaboration with Amgen to provide for the advancement of this novel cardiac muscle activator into studies that are designed to further assess the clinical benefit of this exciting compound. Amgen has consistently demonstrated a successful track record with first-in-class mechanism compounds and we are pleased to be moving forward together."

Conference Call / Webcast

Cytokinetics will host a conference call on Tuesday, May 26, 2009 at 9:00 a.m. Eastern Time. The conference call will be simultaneously webcast and can be accessed in the Investor Relations section of Cytokinetics' website at www.cytokinetics.com. The live audio of the conference call is also accessible via telephone to investors, members of the news media and the general public by dialing either (866) 999-CYTK (2985) (United States and Canada) or (706) 679-3078 (international) and typing in the passcode 11656519. An archived replay of the webcast will be available via Cytokinetics' website until June 9, 2009. The replay will also be available via telephone by dialing (800) 642-1687 (United States and Canada) or (706) 645-9291 (international) and typing in the passcode 11656519 from May 26, 2009 at 1 p.m. Eastern Time until June 9, 2009.

Background on the Collaboration

In December 2006, Cytokinetics and Amgen entered into a strategic collaboration to discover, develop and commercialize novel small-molecule therapeutics that activate cardiac muscle contractility for potential applications in the treatment of heart failure. In connection with the execution of the collaboration and option agreement, Amgen paid Cytokinetics approximately $75 million, comprised of a non-refundable up-front license and technology access fee of $42 million and equity investment of approximately $33 million. At that time, Am
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
4. Amgen to Present at the Cowen and Company Annual Healthcare Conference
5. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
6. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
10. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
11. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Calif., Dec. 10 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Dan Lemaitre, ... the Endologix Board of Directors effective December 11, ... and three non-independent directors. ,, Franklin D. Brown, ... to welcome Dan Lemaitre to the Endologix Board ...
(Date:12/10/2009)... economy and markets exhibiting continued signs of growth, Sidoti ... research provider, will seek to educate investors on a ... market at the firm,s First 2010 Micro Cap ... Hyatt Hotel in New York, NY. ,, ... of Wall Street, but the well-informed investor has the ...
(Date:12/10/2009)... BioSciences Inc. (NYSE Amex: YMI ; TSX: ... identifies and advances a diverse portfolio of promising ... provided an update on the proposed transaction which ... into YM, details of which were announced on ... Cytopia has unanimously recommended that its shareholders vote ...
(Date:12/10/2009)... /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (Nasdaq: CBPO ... the,leading plasma-based biopharmaceutical companies in China, today announced,that ... opening bell at the,NASDAQ MarketSite in New York ... 15,2009. , China Biologic,s ... Market on,December 2, 2009, under the ticker symbol ...
Breaking Biology Technology:Endologix Appoints Dan Lemaitre to its Board of Directors 2Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3
... the second month in a row,the capital markets succumbed to ... of the month the Dow dropped over 300 points after,oil ... Amid these,fears, biotech was dragged down with the Burrill Biotech ... the Dow, which closed down,3%., "The biotech sector started ...
... COPENHAGEN, Denmark and LELYSTAD, Netherlands, March 3, Genmab ... of a research collaboration aimed at identifying fully,human ... those that are difficult to address using,commonly available ... antibodies. These difficulties can for example be due ...
... Pathology LIS Interface to Digital Pathology Information ... ... 3 IMPAC Medical,Systems, Inc. (IMPAC), an Elekta company and ... Aperio Technologies, (Aperio) a global leader in digital pathology for,the ...
Other Biology Technology:Biotech Drops Amid Tough Markets in February 2Biotech Drops Amid Tough Markets in February 3Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology 2IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology 3
(Date:12/14/2009)... The most comprehensive study to date of the ... appendages may provide important clues to how similar regeneration ... the School of Science at Indiana University-Purdue University Indianapolis ... amputated limbs of axolotls, a type of salamander that ... any level of amputation, with the hope that this ...
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/14/2009)... support of the United Nations Framework Convention on ... Environment Agency hosted the ,Bend the Trend, event ... networking platform and premiere the screening of the ... Atlas of Europe, a joint project of the ... (UNEP) and ESA, is a series of short ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Prussian blue linked to the origin of life 2'Environmental Atlas of Europe' unveiled at COP15 2Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 1Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 2Webinar Series Launches for Eye Care Personnel 58108 1Webinar Series Launches for Eye Care Personnel 58108 2Webinar Series Launches for Eye Care Personnel 58108 3Webinar Series Launches for Eye Care Personnel 58108 4NAMSA Unveils New Larger State of the Art Analytical Chemistry Facility 58105 1NAMSA Unveils New Larger State of the Art Analytical Chemistry Facility 58105 2
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Request Info...
Request Info...
Request Info...
Biology Products: